AI Article Synopsis
- The causes and mechanisms of vitiligo remain unclear, hindering diagnosis and effective treatment options.
- There have been national treatment guidelines, but a unified European guideline has not been established until now.
- The new guidelines created by the Vitiligo European Task Force provide evidence-based and expert-based recommendations for treating both segmental and non-segmental vitiligo.
Article Abstract
The aetiopathogenic mechanisms of vitiligo are still poorly understood, and this has held back progress in diagnosis and treatment. Up until now, treatment guidelines have existed at national levels, but no common European viewpoint has emerged. This guideline for the treatment of segmental and nonsegmental vitiligo has been developed by the members of the Vitiligo European Task Force and other colleagues. It summarizes evidence-based and expert-based recommendations (S1 level).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1365-2133.2012.11197.x | DOI Listing |
Publication Analysis
Top Keywords
vitiligo european
8
guidelines management
4
vitiligo
4
management vitiligo
4
european dermatology
4
dermatology forum
4
forum consensus
4
consensus aetiopathogenic
4
aetiopathogenic mechanisms
4
mechanisms vitiligo
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!